The emergence of antibiotic resistance poses a significant challenge to global healthcare. The researchers at the Indian Institute of Science (IISc) and Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) offers promise in the fight against this growing threat.
The research team has developed a rapid diagnostic tool based on a luminescent paper-based platform for detecting the presence of antibiotic-resistant bacteria.
This innovative method utilizes a supramolecular hydrogel matrix containing biphenyl-4-carboxylic acid (BCA) and terbium cholate (TbCh). Terbium’s luminescent properties allow detection through fluorescence upon exposure to ultraviolet (UV) light.
The key lies in the interaction between the hydrogel and the bacteria. When linked to the antibiotic’s cyclic β-lactam ring, the hydrogel emits green fluorescence under UV light.
However, the presence of the β-lactamase enzyme, a hallmark of antibiotic-resistant bacteria, unmasks the sensitizer BCA, leading to green emission even without the antibiotic attached. This elegant design enables rapid and specific detection of resistant bacteria.
The significance of this development lies in its potential to significantly reduce the time to diagnosis. Traditional methods can take days, whereas this novel approach holds the promise of identifying resistant bacteria within two hours.
This swift diagnosis allows for targeted antibiotic therapy, potentially minimizing the selection pressure that drives resistance development. Additionally, the method’s cost-effectiveness through the use of a portable paper-based device makes it accessible for wider implementation.
While this technology requires further testing and validation, it represents a promising step forward in the fight against antibiotic resistance.
By facilitating faster and more accurate diagnosis, it holds the potential to curb unnecessary antibiotic use, a major driver of resistance emergence.
This, in turn, could contribute to preserving the efficacy of existing antibiotics and pave the way for the development of novel therapeutic strategies in the ongoing battle against this global health challenge.
Views: 12